New
SM
Clara Fargo
EBMT Clinical Research Quality Assurance Coordinator
I have finalised the demo for the ICH-GCP E6 R3 refresher course. Overall, I liked the content and the interface. I also want to thank Whitehall Train...
Technology Transfer & Process Validation Lifecycle Course & Certification
Intermediate
Watch Preview
4.8
★★★★★
97% Recommended
3 hours
155 active users
3 points
Watch Preview
Your Study Basket
Technology Transfer & Process Validation Lifecycle
| Total | |
VAT is levied as per your country’s applicable rules and rates at checkout
Save more with a monthly or annual plan that includes this course
Secure Payment Service
Rest assured we use secure processes to protect your payment.
Secured by:
About
Technology Transfer & Process Validation Lifecycle training provides a comprehensive understanding of how pharmaceutical products and manufacturing processes are successfully transferred, validated, and maintained throughout their lifecycle. It focuses on ensuring product quality, process consistency, regulatory compliance, and effective knowledge transfer between development, manufacturing, and commercial operations.
This Technology Transfer & Process Validation Lifecycle Training Course & Certification provides essential knowledge on technology transfer principles, process design, process qualification, continued process verification, validation master planning, risk management, documentation requirements, scale-up activities, change management, regulatory expectations, and lifecycle process validation in accordance with current GMP and ICH guidelines. Upon successful completion, learners receive a certification demonstrating their understanding of technology transfer and process validation lifecycle best practices.
Who Should Enrol?
- Manufacturing, Production, and Operations Personnel
- Quality Assurance and Quality Control Professionals
- Process Development and Technology Transfer Teams
- Validation and Qualification Specialists
- Engineering and Technical Services Personnel
- Regulatory Affairs and Compliance Professionals
- Project Managers involved in product transfers and commercialization
- Anyone responsible for process validation, technology transfer, and GMP compliance
What you will learn
Understand the principles of technology transfer and process validation, including lifecycle approaches for ensuring consistent product quality and regulatory compliance.
Learn the roles and responsibilities of development, manufacturing, quality, engineering, and validation teams during process transfer and commercialization.
Develop knowledge of process design, process qualification, continued process verification, risk management, validation documentation, and change control.
Gain understanding of technology transfer planning, scale-up activities, knowledge management, regulatory expectations, and best practices for maintaining validated processes throughout the product lifecycle.
Course Syllabus
- Why technology transfer and process validation matter - patients, supply and the regulatory stake
- The eight discipline rules the course will not bend
- The process-validation lifecycle - Stage 1, Stage 2 (PPQ) and Stage 3 (CPV) - not a one-off event
- Labelling jurisdiction and document type (FDA/US, EU Annex 15 and EMA, ICH standards, WHO) on every statement
- Technology transfer as knowledge transfer, not a document hand-over
- The Northwind Pharma to Cavendish CMO case study (fictional) and the Veltrixel product
- Why transfer and validation matter - CMO/CDMO scale-up and site transfer
- The process-validation lifecycle and the FDA (2011) three stages
- Mapping FDA, EU Annex 15 and the EMA guideline, ICH and WHO frameworks
- Guidance versus ICH standards versus GMP law - what is binding
- Qualification versus validation, and the sending versus receiving unit
- Northwind and Cavendish: setting up the transfer
- The QTPP, critical quality attributes and critical process parameters (ICH Q8/Q11)
- Design space and the control strategy
- Knowledge management (ICH Q10) - what must actually transfer
- Building the development data package
- Quality by Design and quality risk management underpinning everything
- Northwind: assembling the QbD package and control strategy for Veltrixel
- Governing a transfer project (WHO technology-transfer guidance)
- The sending-versus-receiving gap analysis and receiving-site capability
- The technology-transfer protocol and report
- Quality and technical agreements and clear responsibilities
- The transfer risk assessment
- Northwind to Cavendish: the gap analysis, protocol and quality agreement
- Executing an analytical method transfer
- Managing process fit, scale-up and equipment differences
- Demonstration and engineering batches
- Assessing comparability against the sending unit
- Handling deviations and confirming receiving-site readiness
- Cavendish: the method transfer, scale-up and comparability assessment
- Performing Stage 1 process design and defining the control strategy
- Design of experiments and risk assessment in process design
- Establishing the design space and control strategy for commercial scale
- Producing the process-design output that feeds Stage 2
- Linking development knowledge to the validation approach
- Cavendish: the Stage 1 process-design output for Veltrixel
- Linking Annex 15 qualification (DQ/IQ/OQ/PQ) to Stage 2
- Designing and justifying a PPQ - batches, sampling and acceptance criteria
- Why the PPQ batch count is risk-justified, not a fixed 'three'
- Traditional, continuous-process-verification and hybrid EU approaches
- The PPQ protocol and the PPQ summary report
- Cavendish: a risk-justified PPQ batch, sampling and acceptance plan
- Building a CPV plan and monitoring CQAs and CPPs
- Statistical process control, trending and process capability
- Leading and lagging signals and detecting a drifting parameter
- Feeding CPV back to the control strategy and the annual product review
- Sustaining a state of control across the lifecycle
- Cavendish: a CPV programme detecting a drifting critical process parameter
- Applying ICH Q12 - established conditions, the PACMP and the PLCM document
- Managing post-approval and cross-site change and revalidation triggers
- Recognising when a filing, variation or QP input is required
- Sustaining knowledge management and continual improvement
- Northwind and Cavendish: a post-approval change managed via a PACMP
- The eight discipline rules, revisited
- The transfer-and-validation lifecycle in one page
- Common failures - fixed batch counts, document hand-over, conflated frameworks - and how to avoid them
- What this course does not certify - the disclaimer, restated
- Glossary, references and what to re-verify
- Final assessment and the 80% pass mark
- Certificate of completion and its scope
- 📘 Bonus:Technology Transfer & Process Validation Lifecycle eBook (Free with purchase)
Course Benefits
Free eBook
Get our exclusive eBook with every purchase - a complete companion guide to the course, yours to keep forever
CPD Points
Gain Continuing Professional Development (CPD) Points, accredited by The Faculty of Pharmaceutical Medicine of the Royal College of Physicians of the United Kingdom. These can be used to count towards the distance learning element of any scheme that comes under the umbrella of The Academy of Medical Royal Colleges or any other scheme for which there is mutual recognition.
Certification
Receive a personal certificate to show your subject knowledge on course completion.
Affordable
You get excellent value through our cost-effective prices. We can also offer you group discounts on larger purchases.
Flexibility
The course saves you time through the convenience of online availability. This lets you complete the interactive course at your own comfort.
Keep Up to Date
You will stay up to date with the technology-transfer and process-validation framework and its status across jurisdictions: the FDA Guidance for Industry Process Validation - General Principles and Practices (January 2011) and its Stage 1-2-3 lifecycle (US guidance); EudraLex Volume 4 Annex 15 Qualification and Validation (2015) and the EMA Guideline on Process Validation for finished products, with traditional, continuous-process-verification and hybrid approaches (EU/EEA guidance, applied in the UK via the MHRA); the ICH Q8(R2), Q9(R1), Q10, Q11 and Q12 standards, including established conditions, the PACMP and the PLCM document under Q12 (with regional adoption differences flagged); and WHO technology-transfer guidance (TRS 961 Annex 7 and the updated TRS 1044 Annex 4, 2022) - as our training courses are constantly monitored, reviewed and updated. Guidance is distinguished from ICH standards and from GMP law (US 21 CFR 210/211; EU Directive 2001/83/EC and the GMP Directive); drafts and regional differences are flagged; positions were verified in July 2026 and must be re-verified against the source for the relevant jurisdiction before use.
Learn from Industry Experts
The course content is Whitehall Training editorial material, developed to reflect established technology-transfer and process-validation practice - how a transfer is actually planned, executed and evidenced as knowledge transfer, and how the validation lifecycle is designed and justified on a Quality-by-Design and quality-risk-management basis. It is built around a single fictional case study, Northwind Pharma transferring its solid-oral product Veltrixel to the contract manufacturer Cavendish, so that every gap-analysis, protocol, method-transfer, scale-up, process-design, PPQ, CPV and post-approval-change decision is one the learner can reason through. Regulations, guidance and standards are paraphrased and section-referenced; they are never reproduced, and nothing in the course is legal advice or a regulator endorsement. The course reinforces throughout that validation is a lifecycle, not a one-off event, and that the number of PPQ batches is risk-justified rather than fixed.
Our Certified Customers
Learner Rating & Reviews
4.7
★★★★★★
Average Rating
536 global ratings
★★★★★
87.0%
★★★★★
5.0%
★★★★★
3.0%
★★★★★
3.0%
★★★★★
2.0%
